FAPI PET for Lung Fibrosis
Recruiting
Early Phase 1
Interventional Study
Interstitial Lung Disease
Idiopathic Interstitial Pneumonias
Drug-Induced Pneumonitis
Hypersensitivity Pneumonitis
Radiation Pneumonitis
Pneumoconiosis
Pulmonary Fibrosis
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Trial phase
- Early Phase 1
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 30 (estimated)
- Sponsor
- University of California, Los Angeles · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This is a prospective exploratory biodistribution study in patients with interstitial lung disease (ILD).
The purpose of this research study is to determine where and to which degree the FAPI tracer (68Ga-FAPI-46) accumulates in normal and fibrotic lung tissues of patients with interstitial lung disease.
The study will include patients with interstitial lung disease who have or will initiate a n…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion criteria
* Patients with ILD confirmed by CT at time of staging
* Patients who have initiated or will initiate a new ILD medication with 3 months of enrollment OR Patients who are scheduled to undergo tissue biopsy or surgery of the lung
* Patients are ≥ 18 years old at the time of the ra…
Contacts